Introduction
============

Toxin-antitoxin (TA) systems comprise small genetic modules that modulate microbial cell fates in stressful environments. During periods of low or no stress, antitoxins potently inactivate toxins, thus allowing microbes to grow normally. Under environmental stress, however, antitoxins are preferentially degraded, resulting in toxin activation and subsequent microbial growth arrest ([@B42]). Currently, these systems are grouped into six distinct classes depending on antitoxin features ([@B29]; [@B17]). In type I and type III, the antitoxins comprise RNAs that mask toxin activities by repressing toxin translation or directly binding to corresponding toxins, respectively ([@B8]; [@B14]). In other TA systems, the antitoxins consist of proteins that counteract the toxins by forming a TA protein complex (type II) ([@B13]), functioning as an antagonist of the toxin (type IV) ([@B24],[@B25]), inhibiting translation by destabilising the toxin mRNA (type V) ([@B50]), or serving as an adaptor molecule to introduce the toxin to cellular protease (type VI) ([@B1]). Among these, type II systems have been rigorously investigated and are known to be ubiquitous and abundant in free-living microbes, especially in some chemolithotrophic prokaryotes ([@B30]).

*Nitrosomonas europaea*, which is predicted to carry more than 50 type II TA pairs, is one such chemolithotroph ([@B45]; [@B54]). *N. europaea* obtains energy and reductants by oxidising ammonia to nitrite ([@B4]; [@B5]), inhabiting wastewater treatment and sediments where ammonia may be in abundant supply ([@B20]). As the oxidation process is important in terms of industrial, agricultural, and environmental nitrogen cycles ([@B7]), the physiology, biochemistry, and molecular biology of this bacteria in varied environments has been investigated. It has been well documented that *N. europaea* is susceptible to numbers of environmental factors such as temperature, pH, nitrite and ammonia concentrations, heavy metals, and organic and inorganic compounds ([@B15]; [@B46]; [@B20]; [@B52],[@B53]; [@B32],[@B33]; [@B35]; [@B55]; [@B34]). Considering that *N. europaea* harbours a very high number of putative TA pairs ([@B30]), this bacterium might regulate cellular activities using type II toxins.

Among the putative *N. europaea* toxins, a great majority are predicted to catalyse cellular RNA decay ([@B30]; [@B45]; [@B54]); *Escherichia coli* MazF, a sequence-specific toxin endoribonuclease ([@B56]), provides a helpful basis to better understand these endoribonucleolytic toxins in *N. europaea*. In the absence of stresses, MazF-mediated RNA cleavage is neutralised by its cognate antitoxin MazE ([@B56]). Environmental stresses such as starvation, high temperature, and oxidative stress ([@B18]), however, trigger MazE degradation via the ClpAP protease ([@B2]), activating the MazF endoribonuclease. *E. coli* MazF then comprehensively alters the translation profile by cleaving transcripts at ACA sites ([@B3]; [@B38]). MazF homologues are widely distributed in the prokaryotic domain ([@B11]), with a hallmark of these enzymes being their sequence-specificities ([@B23]; [@B41]). Typically, MazF toxins recognise three to seven specific-sequences (i.e., ACA, UACAU, and UUACUCA), suggesting that the biological roles of MazF homologues are diverse and differ across microbial species ([@B59], [@B58], [@B57]; [@B31]; [@B36]; [@B39], [@B40]; [@B43]; [@B48]; [@B27], [@B28]; [@B22]).

Notably, five *mazEF* loci are predicted in the *N. europaea* genome, whereas only one is found in the majority of prokaryotes ([@B30]; [@B11]). The cleavage-specificities of these endoribonucleases are less well studied and largely unknown, except for one located at the ALW85_RS06130 locus (previously designated as NE1181) ([@B27]); therefore, detailed analysis is required to interpret their physiological functions. In the present work, we focused our study on the predicted MazF endoribonuclease located at ALW85_RS04820 (hereafter MazFne1; [@B30]) and revealed that it codes for a functional toxin endoribonuclease. Our study suggests that MazFne1 may serve as a crucial regulator of translation and cellular activities.

Materials and Methods {#s1}
=====================

Plasmids and Oligonucleotides
-----------------------------

The pET24a expression vectors encoding *mazE*ne1 and pET24a encoding *mazF*ne1 were purchased from GenScript Japan (Tokyo, Japan). The sequences of both genes were optimised for recombinant protein expression in *E. coli*. PCR primers were purchased from Tsukuba Oligo Service (Ibaraki, Japan). All fluorescently labelled oligonucleotides were purchased from Japan Bio Services (Saitama, Japan).

Reverse Transcription (RT)-PCR
------------------------------

*Nitrosomonas europaea* ATCC 19718 was obtained from the Biological Resource Center (NBRC), National Institute of Technology and Evaluation (NITE), Japan. *N. europaea* was cultivated in the dark at 28°C. HEPES medium 829 was used as the growth medium, as described in the NBRC manual. Cells were harvested by centrifugation at 2900 g. The cell pellet was transferred to a 2 mL screw-cap tube containing glass beads (0.1 mm in diameter) and disrupted in TRI-Reagent (Zymo Research, Orange, CA, United States). Total RNA was extracted using the Direct-zol^TM^ RNA MiniPrep Kit (Zymo Research) according to the manufacturer's protocol. Extracted RNA was then incubated with 4U of TURBO DNase (Thermo Fisher Scientific, Waltham, MA, United States) in the TURBO DNase Buffer at 37°C for 1 h and purified with RNA Clean and Concentrator^TM^-5 (Zymo Research). Resultant RNA was incubated at 65°C for 5 min and cDNA was synthesised using the SuperScript VILO cDNA Synthesis Kit (Thermo Fisher Scientific) according to the manufacturer's protocol. PCR was carried out with Q5 High-Fidelity DNA Polymerase (New England Biolabs, Ipswich, MA, United States) using the primers listed in **Supplementary Table [1](#SM1){ref-type="supplementary-material"}**. PCR conditions were as follows: an initial denaturation at 98°C for 1 min, followed by 30 cycles of amplification (denaturation at 98°C for 10 s, annealing at 65°C for 15 s, and extension at 72°C for 20 s), and a final extension for 2 min at 72°C. The samples were separated on a 2% agarose gel and visualized by GelRed^TM^ Nucleic Acid Gel Stain (Biotium, Inc., Fremont, CA, United States).

Toxicity Assay
--------------

*E. coli* strain BL21 (DE3) cells (BioDynamics Laboratory Inc., Tokyo, Japan) were transformed with pET24a-*mazF*ne1. These cells were pre-cultivated overnight in LB medium supplemented with 50 μg/mL kanamycin at 37°C. Cells were diluted 1:1000 in 10 mL of LB medium containing 50 μg/mL kanamycin. MazFne1 was induced by the addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) when the OD~600~ reached approximately 0.1. OD~600~ was measured at every 30 min.

Expression and Purification of MazEne1
--------------------------------------

Recombinant MazEne1 was obtained as outlined in our previous study ([@B27]) with slight modifications. *E. coli* strain BL21 (DE3) cells (BioDynamics Laboratory Inc.) were transformed with pET24a-*mazE*ne1. These cells were pre-cultivated overnight in LB medium supplemented with 20 μg/mL kanamycin at 37°C. Subsequently, they were inoculated into 1 L of LB medium containing 20 μg/mL kanamycin. MazEne1 was induced by the addition of 1 mM IPTG when the OD~600~ reached approximately 0.6. After 3.5 h of incubation, the cells were harvested by centrifugation at 9200 g and stored at -80°C until further use. *E. coli* cells containing MazE were thawed on ice and resuspended in 18 mL of binding buffer (20 mM sodium phosphate buffer (pH 8.0), 300 mM NaCl, 40 mM imidazole, and 5 mM 2-mercaptoethanol). Subsequently, these cells were lysed by sonication and collected by centrifugation at 4400 g. The supernatant was filtered through a 0.45 μm membrane (Millex, Darmstadt, Germany), and applied to an equilibrated 1 mL His-Trap FF crude column (GE Healthcare, Little Chalfont, United Kingdom). The column was washed with 40 column volumes of binding buffer using AKTA pure 25 (GE Healthcare). Histidine-tagged MazE was selectively eluted with the elution buffer (20 mM sodium phosphate buffer (pH 8.0), 300 mM NaCl, 500 mM imidazole, and 5 mM 2-mercaptoethanol) using the following program: flow rate, 1 mL/min; linear elution gradient, 20 column volumes; fraction size, 0.5 mL. The 18th fraction from the beginning of the elution program was used for further experiments. The molecular weight and purity were confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS--PAGE). Protein concentration was determined using the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, United States).

Expression and Purification of MazFne1
--------------------------------------

Recombinant MazFne1 was expressed and purified as described previously with minor modifications ([@B27]). *E. coli* strain BL21 (DE3) cells (BioDynamics Laboratory Inc.) was transformed with pET24a-*mazF*ne1. The transformant was cultivated overnight in LB medium supplemented with 20 μg/mL kanamycin at 37°C and inoculated into 1 L LB medium containing 20 μg/mL kanamycin. MazF was induced by the addition of 1 mM IPTG when the OD~600~ reached approximately 4.0. After 3.5 h of incubation, the cells were harvested by centrifugation at 9200 g and stored at -80°C. The cells containing MazFne1 were thawed on ice and resuspended in 18 mL of binding buffer (20 mM sodium phosphate buffer (pH 8.0), 300 mM NaCl, 40 mM imidazole, and 5 mM 2-mercaptoethanol). The cells were lysed by sonication and collected by centrifuging at 4400 g for 15 min. The supernatant was then filtered through a 0.45 μm membrane (Millex). After equilibrating a 1 mL His-Trap FF crude column (GE Healthcare), the supernatant was applied to the column and washed with 55 column volumes of binding buffer using AKTA pure 25 (GE Healthcare). Hexa-histidine tagged MazFne1 was selectively eluted using the following program: flow rate, 1 mL/min; linear elution gradient, 20 column volumes; fraction size, 0.5 mL. The elution buffer contained 20 mM sodium phosphate buffer (pH 8.0), 300 mM NaCl, 500 mM imidazole, and 5 mM 2-mercaptoethanol. The 17th and 18th fractions from the beginning of the elution program were used for further experiments. The molecular weight and purity were confirmed using SDS--PAGE. Protein concentration was determined using a Bio-Rad Protein Assay (Bio-Rad).

Enzymatic Activity of MazF and MazE
-----------------------------------

Synthetic RNA constructs were prepared as described in our previous study ([@B26]). RNA 500-2 (100 ng) was incubated with 1, 3, or 10 pmol of MazF at 37°C for 90 min in MazF reaction buffer \[20 mM Tris--HCl (pH 8.0), 1 mM dithiothreitol, 0.01% Triton X-100, and 4 U of recombinant RNase inhibitor (TaKaRa, Shiga, Japan)\] in a 50 μL reaction volume. As a control reaction, 10 pmol of MazF was pre-incubated with 50 pmol of MazE at 25°C for 10 min, and this mixture was incubated with 100 ng of RNA 500-2 at 37°C for 90 min in MazF reaction buffer. These RNAs were purified with RNA Clean and Concentrator^TM^-5 (Zymo Research). Gel loading buffer II (Ambion, Austin, TX, United States) was added to each sample followed by incubation at 95°C for 5 min. Samples were separated on a 10% polyacrylamide gel containing 7 M urea. The RNA was stained using SYBR Gold (Life Technologies) and detected using a Typhoon 9210 imager (GE Healthcare).

Cleavage Sequence Identification
--------------------------------

The cleavage sequence was identified using the protocols described in our previous study ([@B26], [@B28]). Briefly, 0.625 pmol of eight RNA mixtures (500-2, 1000-1, 1000-2, 1000-3, 1000-4, 1000-5, 1500-1, and 2000-1) were incubated with 50 ng of MazFne1 at 37°C for 30 min in MazF reaction buffer. Phosphorylation, barcode ligation, and sequencing library construction were performed as described previously ([@B26], [@B28]). Sequencing was performed using the MiSeq platform with the MiSeq 500 cycles reagent kit v2 (Illumina, San Diego, CA, United States) according to the manufacturer's protocol. Sequence data were analysed using CLC Genomics 7.5.1 (Qiagen, Venlo, The Netherlands). The parameters described in our previous study ([@B26], [@B28]) were used for the analysis. We added pseudo-counts to the nucleotide positions whose coverages were 0, and calculated the relative coverage increase, the value defined as the coverage at the (*n* + 1)th position divided by the coverage at the *n*th position. Nucleotide positions with coverage less than 100 were excluded from analysis. Of these nucleotide positions, those showing the overall top 50 relative coverage increases were selected from all references. The sequences five-base pairs upstream and downstream of these positions were extracted and aligned using WebLogo ([@B12]). These sequence data were submitted to the DDBJ database under the accession number [DRA006546](DRA006546).

Fluorometric Assay
------------------

The fluorometric assay was carried out as outlined in our previous study ([@B26],[@B27]). Briefly, 0.7 pmol of MazFne1 or 100 ng of RNase A was incubated with 20 pmol of fluorescently labelled oligonucleotides in MazF reaction buffer in a total volume of 20 μL. As a control reaction, 0.7 pmol of MazFne1 was pre-incubated with 3.5 pmol of MazEne1 at 25°C for 10 min, and this mixture was incubated with 20 pmol of fluorescently labelled oligonucleotides in MazF reaction buffer in a total volume of 20 μL. All reactions were conducted at 37°C in triplicate and fluorescence intensity was recorded every 1 min using a Light Cycler 480 system (Roche, Basel, Switzerland) with 483 nm excitation and 533 nm detection filters.

Analysis of UGG Frequency in *N. europaea* Coding Sequences
-----------------------------------------------------------

Statistical analysis was performed as outlined in a previous study ([@B57]). Protein-coding sequences of *N. europaea* were retrieved from the NCBI database. The CDS data as of February 10, 2018 were used for the analysis. The following parameters were taken into account: (i) *p* is the probability of TGG appearing in a *N. europaea* gene and represents the product of (percentage of U) multiplied by (percentage of G)^2^; (ii) *L* represents the length of each coding sequence (CDS); (iii) *E* is the expected number of TGG motifs in a CDS and is calculated as *p*(*L* -- 2); (iv) *K* is the actual number of TGG sequence in a CDS; and (v) *P* represents the probability of each CDS containing TGG motifs at least *K* times. *P* is given by:
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Accession Numbers
-----------------

The GenBank accession numbers are as follows: artificially designed RNAs: 500-2 ([AB610940](AB610940)), 1000-1 ([AB610944](AB610944)), 1000-2 ([AB610945](AB610945)), 1000-3 ([AB610946](AB610946)), 1000-4 ([AB610947](AB610947)), 1000-5 ([AB610948](AB610948)), 1500-1 ([AB610949](AB610949)), and 2000-1 ([AB610950](AB610950)); *N. europaea* genome ([NC_004757](NC_004757)); MazEne1 ([WP_041356592](WP_041356592)); MazFne1 ([WP_011111532](WP_011111532)).

Results
=======

MazFne1 Constitutes a Toxic Protein That Is Co-transcribed With Its Upstream Gene
---------------------------------------------------------------------------------

Although the putative ORF existing immediately upstream of the *mazF* gene, encoded at ALW85_RS04820 (originally annotated as NE0921; *mazF*ne1), was not initially annotated ([@B10]), bioinformatics analysis predicted that it codes for the MazE counterpart (MazEne1) (**Supplementary Figure [1A](#SM1){ref-type="supplementary-material"}**) ([@B30]), with MazEne1 and MazFne1 exhibiting 20.7 and 18.7% amino acid sequence identities to those of *E. coli*, respectively (**Supplementary Figure [1B](#SM1){ref-type="supplementary-material"}**). Moreover, the *mazEF*ne1 genes are organised in a manner fully consistent with the type II TA system ([@B44]), with an 11 bp overlap between *mazE*ne1 and *mazF*ne1 (**Supplementary Figure [2A](#SM1){ref-type="supplementary-material"}**).

A common feature of type II TA systems is their operon structure ([@B13]). To investigate whether the putative *mazEF* genes are co-transcribed in *N. europaea*, we carried out reverse transcription (RT)-PCR using three different primer sets (**Supplementary Figure [2A](#SM1){ref-type="supplementary-material"}**, upper panel): one for the *mazE*ne1 gene (primers 1 and 2), another for *mazF*ne1 (primers 3 and 4), and the third for *mazEF*ne1 (primers 1 and 4). In all cases, we observed amplification only in the presence of reverse transcriptase (**Supplementary Figure [2A](#SM1){ref-type="supplementary-material"}**, lower panel), demonstrating that *mazE*ne1 and *mazF*ne1 are co-transcribed.

Another key feature of TA pairs is the effect of toxin expression on bacterial growth. To briefly investigate whether MazFne1 constitutes a toxin, we constructed an expression plasmid, in which the *mazF*ne1 gene was under the control of an IPTG-inducible promoter, and examined whether MazFne1 overexpression retarded *E. coli* growth. As shown in **Supplementary Figure [2B](#SM1){ref-type="supplementary-material"}**, MazFne1 induction led to stable growth arrest, indicating that *mazF*ne1 indeed codes for a toxin. Taken together, these results suggest that MazEFne1 constitutes a TA system.

MazFne1 Forms a TA System With Its Cognate Antitoxin MazEne1
------------------------------------------------------------

To evaluate whether MazEFne1 functions as a TA system at the molecular level, we purified these enzymes using affinity chromatography (**Figure [1A](#F1){ref-type="fig"}**). As shown in **Figure [1B](#F1){ref-type="fig"}**, dose-dependent RNA degradation was detected following treatment of the RNA substrate with MazFne1, suggesting that MazFne1 constitutes an endoribonuclease (**Figure [1B](#F1){ref-type="fig"}**, lanes 2--4). Notably, the substrate remained intact when MazEne1 was added prior to RNA exposure (**Figure [1B](#F1){ref-type="fig"}**, lane 5); thus, the observed RNA cleavage was catalysed by MazFne1 but not by contaminating RNases. From these results, we concluded that the *mazEF*ne1 locus encodes a functional TA system.

![MazEF homologue isolated from *N. europaea* and their enzymatic activities. **(A)** Molecular weight and purity of MazEne1 and MazFne1. **(B)** A 533-nt artificially designed RNA (RNA 500-2) was incubated with MazEne1 and/or MazFne1: lane 1, a control reaction in the absence of enzymes; lanes 2--4, 1, 3, and 10 pmol of MazFne1 was added, respectively; lane 5, 10 pmol of MazFne1 was pre-incubated with 50 pmol of MazEne1 and RNA 500-2 was subsequently added; lane 6, 50 pmol of MazEne1 was added; lane 7, ladder.](fmicb-09-02386-g001){#F1}

Modified RNA-Seq Indicates That UGG Is Necessary for MazFne1 Cleavage
---------------------------------------------------------------------

Having confirmed the endoribonuclease activity of MazFne1, we proceeded to define its cleavage-specificity. Toward this end, we utilised a specialised RNA-Seq that we have recently developed ([@B26]). In this approach, we digested eight artificially designed RNAs containing diverse 500--2000 nt sequences (500-2, 1000-1, 1000-2, 1000-3, 1000-4, 1000-5, 1500-1, and 2000-1) with MazFne1, and analysed the 5′-end sequences of the fragmented RNAs. As MazF digests RNA at specific sequence motifs, reads carrying particular sequences at their 5′ boundaries, which match the MazF-cleaved sites, are enriched. Accordingly, the coverage tends to increase at corresponding nucleotide positions (**Figure [2A](#F2){ref-type="fig"}**; [@B26]).

![Analysis of the cleavage sequence of MazFne1. **(A)** Coverage (grey bar) and relative coverage increase (RCI; orange line), which is the value defined as the ratio of coverage at the (*n* + 1)th position to coverage at the *n*th position. **(B)** Nucleotide appearance frequency was visualised using WebLogo ([@B12]). The black arrow indicates the position of the cleavage site.](fmicb-09-02386-g002){#F2}

To estimate the sequence determinants for MazFne1 cleavage, we extracted the sequences five bases up- and downstream of the identified nucleotide positions. After aligning the overall top 50 sequences, we found a strong consensus motif, UGG, from -1 to 1 positions (where the nucleotide position with coverage increase was numbered as zero; **Figure [2B](#F2){ref-type="fig"}, Supplementary Table [2](#SM1){ref-type="supplementary-material"}**), suggesting that MazFne1 requires UGG triplets for its endoribonuclease activity and cut RNAs between U and the first G.

UGG Is the Target of MazFne1
----------------------------

To further determine the sequence requirements of MazFne1, we adopted a fluorescence quenching technique and prepared oligonucleotides (listed in **Table [1](#T1){ref-type="table"}**) that were modified with 6-carboxyfluorescein (6-FAM) on the 5′-end and black hole quencher-1 (BHQ-1) on the 3′-end. Because these 2 dyes are tethered by nucleotides and are in close vicinity, the fluorescence of 6-FAM is dampened. As these oligonucleotides are degraded, however, unquenched 6-FAM molecules accumulate, resulting in an increase in fluorescence intensity ([@B49]).

###### 

Fluorogenic oligonucleotides used in this study.

  Name         Sequence (5′--3′)^a^
  ------------ ----------------------
  DR-13-UGG    AAAAA[UGG]{.ul}AAAAA
  D-13-AAA     AAAAAAAAAAAAA
  R-13-UCUCG   [UCUCGGUGCGUUG]{.ul}
  R-13-UGACA   [UGACACGAACCGC]{.ul}
  R-13-GUUGU   [GUUGUCAUGCCGG]{.ul}
  DR-13-CGG    AAAAA[CGG]{.ul}AAAAA
  DR-13-UGA    AAAAA[UGA]{.ul}AAAAA
  DR-13-UGU    AAAAA[UGU]{.ul}AAAAA
  DR-13-UGC    AAAAA[UGC]{.ul}AAAAA
               

a

Underlined letters represent RNA nucleotides, whereas other letters represent DNA nucleotides.

We sought to determine the MazFne1 target by monitoring the signal from 6-FAM. To corroborate the RNA-Seq result, we firstly utilised DR-13-UGG, which is a DNA-RNA chimeric oligonucleotide containing a UGG triplet in the middle of adenine repeats. As we anticipated, the oligonucleotide was sensitive to MazFne1 (**Figure [3A](#F3){ref-type="fig"}**, green plot). The cleavage was specifically caused by MazFne1 and was considered to occur at RNA nucleotide sites, because (i) cleavage activity was completely blocked upon MazEne1 addition (**Figure [3A](#F3){ref-type="fig"}**, yellow plot), and (ii) no detectable change in fluorescence intensity was observed when D-13-AAA, a DNA oligonucleotide, was used instead as the substrate for MazFne1 (**Figure [3B](#F3){ref-type="fig"}**).

![Sequence-specific RNA cleavage with MazFne1; 0.7 pmol of MazFne1 (green) or MazFne1 pre-incubated with 3.5 pmol of MazEne1 (yellow) was incubated with 20 pmol of fluorogenic oligonucleotides: **(A)** DR-13-UGG, **(B)** D-13-AAA, **(C)** R-13-UCUCG, **(D)** R-13-UGACA, **(E)** R-13-GUUGU, **(F)** DR-13-CGG, **(G)** DR-13-UGA, **(H)** DR-13-UGU, or **(I)** DR-13-UGC. In the control reactions, fluorescence intensities in the presence of 100 ng of RNase A (blue) and absence of enzymes (orange) at each time point (left) and the end point (right) were measured.](fmicb-09-02386-g003){#F3}

We next prepared three additional RNA oligonucleotides (R-13-UCUCG, R-13-UGACA, and R-13-GUUGU), whose sequences are identical to that of RNA 1000-4 (one of the substrates used in the modified RNA-Seq) but lack the UGG motif. As expected, these RNAs were also tolerant to MazFne1 (**Figures [3C](#F3){ref-type="fig"}--[E](#F3){ref-type="fig"}**). The results were concordant with the result from the modified RNA-Seq, suggesting that UGG is the target of MazFne1.

Lastly, we synthesised four DNA-RNA chimeric oligonucleotides (DR-13-CGG, DR-13-UGA, DR-13-UGU, and DR-13-UGC) to investigate whether MazFne1 cleaves 3-base motifs similar to UGG. As shown in **Figures [3F](#F3){ref-type="fig"}--[I](#F3){ref-type="fig"}**, none of these oligonucleotides were degraded. Taken together, our findings demonstrated that MazFne1 constitutes an endoribonuclease that specifically cleaves the UGG triplet.

The UGG Motif Is Abundant in Genes That Are Unique in the Ammonia-Oxidising Bacteria
------------------------------------------------------------------------------------

The number of cleavage sequences in a transcript has been shown to correlate with mRNA stabilities ([@B57]; [@B40]). To evaluate the potential effect of MazFne1 on *N. europaea* cells, we performed statistical analysis and searched for genes containing multiple TGG sequences ([@B57]) among the 2,646 coding sequences (CDS) identified in this organism. Specifically, we counted the actual number of TGG triplets in each CDS (*K*) and calculated the probabilities of each transcript containing *K* times or more TGG motifs (*P*), on the basis of nucleotide contents and the length of each CDS (**Figure [4](#F4){ref-type="fig"}**). Notably, when we extracted the top 10 CDS with the smallest *P-*values, the *hao* and *rbcL* genes, which are indispensable for ammonia oxidation and CO~2~ fixation, respectively, were detected (**Table [2](#T2){ref-type="table"}**). As the CDS showing small *P*-values are considered to be preferentially digested, MazFne1 may serve to efficiently repress *N. europaea* cellular activities (see Discussion).

###### 

Predicted prime targets of MazFne1.

  Rank   Location           Gene symbol   Gene product                                                   Length (bp)   Expected (*E*)^a^   Actual (*K*)^b^   *P*^c^
  ------ ------------------ ------------- -------------------------------------------------------------- ------------- ------------------- ----------------- ----------
  1      c199041-189847     --            Type I secretion C-terminal target domain containing protein   9195          89.43               157               5.30E-11
  2      1783631--1786309   --            Dolichyl-phosphate beta-D-mannosyltransferase                  2679          41.25               79                8.75E-08
  3      c436078-432929     *hsdR*        Type I restriction endonuclease subunit R                      3150          52.46               94                1.16E-07
  4      c1048744-1047032   *hao2*        Hydroxylamine_oxidoreductase                                   1713          23.91               52                3.56E-07
  5      c2215518-2213806   *hao1*        Hydroxylamine_oxidoreductase                                   1713          23.91               52                3.56E-07
  6      c2540363-2538651   *hao3*        Hydroxylamine_oxidoreductase                                   1713          23.91               52                3.56E-07
  7      c2076037-2074616   *rbcL*        Ribulose bisphosphate carboxylase large chain                  1422          25.22               53                7.15E-07
  8      c1601334-1600138   --            Aminotransferase                                               1197          22.82               49                9.90E-07
  9      1894644-1898096    --            Antibiotic resistance protein VanZ                             3453          50.25               87                1.33E-06
  10     c988550-986691     *ftsH*        ATP-dependent metallopeptidase FtsH/Yme1/Tma family protein    1860          33.60               64                1.54E-06
                                                                                                                                                             

a

E represents the expected motif count.

b

K represents the actual motif count.

c

P represents the probability of each transcript containing K times or more TGG motifs. A very small P-value indicates that the CDS may be the prime target of MazFne1.

![Relationship between the actual number of TGG triplets (*K*) and *P-*values in each CDS. A very small *P-*value indicates that the CDS is preferentially degraded by MazFne. Dots correspond to *hao*, and *rbcL* transcripts are highlighted.](fmicb-09-02386-g004){#F4}

Discussion
==========

Microbes have to cope with sudden environmental alterations. A propitious strategy to survive in fluctuating surroundings is to regulate growth, with prokaryotic TA systems being a well-known example of such a strategy ([@B17]). In the present study, we characterised one of these representative TA systems, the MazEF family, encoded on the *N. europaea* chromosome. We found that MazEFne1 shares typical features of type II TA pairs: first, *mazE*ne1 and *mazF*ne1 are co-transcribed in *N. europaea* (**Supplementary Figure [2A](#SM1){ref-type="supplementary-material"}**); second, ectopic expression of MazFne1 is toxic to bacterial cells (**Supplementary Figure [2B](#SM1){ref-type="supplementary-material"}**); third, MazFne1 possesses endoribonuclease activity and MazEne1 counteracts its enzymatic activity (**Figure [1](#F1){ref-type="fig"}**); and fourth, MazFne1 specifically cleaves RNA at the UGG motif (**Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}**).

Five MazF family members are encoded in the *N. europaea* chromosome. Although the sequence-specificities of these enzymes are not completely elucidated, they are, similar to other MazF homologues, considered to have different targets, triggers, and roles ([@B37]; [@B18]; [@B47]; [@B16]; [@B41]), because of their low sequence similarities and distinct loci. Indeed, we have previously shown that the *N. europaea* MazF encoded at ALW85_RS06130 (MazFne3; **Supplementary Figure [1A](#SM1){ref-type="supplementary-material"}**) is an AAU-specific cutter. To the best of our knowledge, no stresses that activate MazFne1 have been identified. Further studies are needed to understand how these enzymes are beneficial to environmental fluctuations.

*N. europaea* production of reductant and energy via ammonia oxidation has been well elucidated. The process comprises a sequential oxidation reaction of ammonia to hydroxylamine (NH~3~ to NH~2~OH) and hydroxylamine to nitrite (NH~2~OH to NO~2~^-^); the former is catalysed by ammonia monooxygenase (AMO) and the latter by hydroxylamine oxidoreductase (recently designated as hydroxylamine dehydrogenase) (HAO) and putatively by nitric oxide oxidase ([@B9]). Four electrons are released through hydroxylamine oxidation, half of which are used for ammonia oxidation and the other half for proton gradient formation, followed by ATP and NADH production ([@B4]; [@B5]). In the present study, we found that TGG triplets are strikingly abundant in the three copies of the *hao* genes (**Table [2](#T2){ref-type="table"}**). Notably, these triplets are also relatively rich in *amo* genes (**Table [3](#T3){ref-type="table"}**). Conceivably, the AMO and HAO transcripts are destabilised when MazFne1 is activated in *N. europaea* cells, thereby inhibiting cellular activities requiring energy and reductant.

###### 

Actual and expected numbers of TGG motifs in *amo* genes^a^.

  Gene symbol   Gene product                              Length (bp)   Expected (*E*)      Actual (*K*)   *P*
  ------------- ----------------------------------------- ------------- ------------------- -------------- ----------------------------
  amoC1/C2/C3   Ammonia monooxygenase, subunit C1/C2/C3   816/816/825   17.69/18.34/15.18   39/38/36       6.24E-06/3.09E-05/2.98E-06
  amoA1/A2      Ammonia monooxygenase, subunit A1/A2      825/825       17.90/17.90         33/33          7.59E-04/7.59E-04
  amoB1/B2      Ammonia monooxygenase, subunit B1/B2      1263/1263     21.48/21.48         41/41          9.85E-05/9.85E-05
                                                                                                           

a

E, K, and P represent values identical to those shown in

Table

2

.

Moreover, in addition to ammonia oxidation, carbon fixation would also likely be impaired. *N. europaea* utilises the Calvon-Benson-Bassham (CBB) cycle to fix carbon dioxide ([@B10]), with this step being initiated by a type I ribulose 1,5-bisphosphate carboxylase/oxygenase (RubisCo), which is composed of a large subunit and small subunits ([@B51]). In our analysis, the *rbcL* gene, encoding the large subunit of RubisCo, is predicted to be sensitive to MazFne1 (**Table [2](#T2){ref-type="table"}**). Taken together with the fact that in *N. europaea*, the CBB cycle is powered by ATP and NADH generated from ammonia oxidation ([@B10]), MazFne1 would supposedly severely compromise the biosynthesis processes of this bacterium.

It has been previously observed that type II TA systems are abundant in some slowly growing bacteria, including *N. europaea* ([@B30]). Although it remains unclear why these seemingly redundant TA pairs exist in this bacterium, the number of TA pairs might be associated with the growth rate. Indeed, 99.9% of *N. europaea* coding sequences contain at least one TGG motif. Presumably, MazFne1 arrests *N. europaea* growth by directly shutting down almost all protein synthesis, in addition to the indirect downregulation of many biochemical reactions through the inhibition of ammonia oxidation and carbon fixation. Given that a low metabolic state represents a common bacterial strategy to improve stress resistance and that TA systems are implicated in the formation of such states, referred to as "dormant and/or viable but non-culturable" ([@B19]; [@B21]; [@B6]; [@B47]), *N. europaea* might withstand environmental stresses with the aid of MazFne1.

In summary, we found that MazFne1 codes for a functional endonucleolytic toxin and constitutes a TA pair with its cognate antitoxin, MazEne1. Additionally, MazFne1 digests RNAs at UGG sites in a ribosome-independent manner. Our finding indicates that *N. europaea* might benefit from the growth modulation mediated by MazFne1 under stressful conditions.
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